Linda Russell (on behalf of the UK investigators)
This study presents the preliminary findings of UK data from a larger international outcomes evaluation of a silver-releasing foam dressing, Contreet Foam Dressing™ (manufactured by Coloplast A/S).
To carry out a comparative outcomes assessment of clinical performance of Contreet Foam vs local best practice in the treatment of chronic wounds.
This study was comparative, open, prospective, parallel, and block-randomised. A total of 82 patients were included and were recruited from chronic wound clinics. Patients were randomised to a 4-week treatment period with either Contreet Foam or local best practice.
Findings indicate that Contreet Foam has greater ease of application and removal (p=0.0003), enhanced fluid absorption (32% vs 56% leakage), leakage control (p=0.0032), odour reduction, and prolonged wear time (4.2 vs 3.4 days), and a 50% relative reduction in wound area from baseline during the study.
These preliminary results support faster wound healing with Contreet Foam vs best local practice.